Pnc Financial Services Group, Inc. Rigel Pharmaceuticals Inc Transaction History

Pnc Financial Services Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$1.12 - $1.57 $1,120 - $1,570	-1,000 Reduced 9.09%	10,000 $14,000
Q3 2023 Nov 13, 2023	BUY	$1.07 - $1.39 $1,070 - $1,390	1,000 Added 10.0%	11,000 $11,000
Q3 2022 Nov 10, 2022	SELL	$1.1 - $12.2 $710 - $7,881	-646 Reduced 6.07%	10,000 $0
Q3 2021 Nov 05, 2021	BUY	$3.5 - $4.5 $2,261 - $2,907	646 Added 6.46%	10,646 $38,000
Q4 2020 Feb 12, 2021	BUY	$2.35 - $3.74 $23,500 - $37,400	10,000 New	10,000 $35,000

334K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.84B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.